It is critical that we build and maintain our rich tradition of clinical expertise in support of developing life-changing medicines for patients. Jose Baselga
The Baselga Cancer Research Scholars Program now in its sixth year is a 2-year immersive education and research program for early-career Oncologists who are inspired by science and by how clinical development has the potential to transform patient care. As part of a competitively selected cohort of Scholars you will be based in Oncology R&D with an opportunity to learn from a diverse group of experts across the drug development continuum playing a pivotal role in channelling our scientific capabilities to make a positive impact on changing patients lives. Selected Scholars will join the current cohort of Baselga Cancer Research Scholars to build a strong community of drug developers. We are currently recruiting for the 2026 class with an aim to start the position in summer-autumn 2026.
About AstraZeneca Oncology Research & Development
Our Oncology strategy is built with one goal in mind pushing the boundaries of science to deliver life-changing medicines to patients. We have a passion for discovery and a broad pipeline of next-generation medicines and together with a focus on execution excellence we aim to expand treatment options and improve outcomes for patients with solid and haematological cancers. Were pioneering innovative research across six scientific platforms: Tumor drivers and resistance; Immuno-oncology DNA damage response Antibody drug conjugates Epigenetics and Cell therapies.
Our ambition is to eliminate cancer as a cause of death. Its our big vision that unites and inspires us. With multiple indications and high-quality molecules at all stages of our innovative pipeline we keep pushing forward. Focusing on cutting-edge science with the latest technology to achieve breakthroughs. AZ is a place built on courage curiosity and collaboration we make bold decisions driven by patient outcomes.
What youll do
The 2026 AZ Baselga Cancer Research Scholars cohort will join AstraZeneca at a time of tremendous growth and acceleration in the oncology biologics portfolio. Working in a fast-paced and dynamic work environment you will experience increasing levels of responsibility following a structured learning plan in the following domains:
1) Clinical Study Assignment: You will join a clinical study team and build experience as a medical leader in clinical development which could be in Early Clinical Development Late Clinical Development or one year in each. You will participate in weekly clinical and scientific meetings related to your clinical study complete AstraZeneca training programs and participate in internal and external scientific meetings. You will work in a cross functional environment . contributing to and supporting Department/Clinical initiatives to improve the quality and content of all clinical programs as well as the cross functional/organization processes designed to effectively deliver our R&D portfolio.
Specific duties and major responsibilities for the longitudinal medical project may include any of the following:
2) Rotational program: During the course of your program you will be involved in 3-6 month long rotations across various groups to gain a better understanding of the cross-functional departments. This could include:
3) Longitudinal Research Project: You will have opportunity to undertake a research project for the duration of the 2-year program which may be an area of specialist interest to you and AstraZeneca or alternatively focus on one or more of the rotational functions. The intent is that this will be presented at the end of the Program to key internal stakeholders as well as at a key scientific meeting and published in a peer-reviewed journal.
Essential for the role:
2 - 3 years of clinical oncology training required
Highly Desirable for the role:
So whats next
Complete your application before the below closing date.
Where can I find out more
Follow AstraZeneca on LinkedIn AstraZeneca on Facebook AstraZeneca on Instagram Posted
20-Jan-2026Closing Date
22-Jan-2026Our mission is to build an inclusive environment where equal employment opportunities are available to all applicants and furtherance of that mission we welcome and consider applications from all qualified candidates regardless of their protected characteristics. If you have a disability or special need that requires accommodation please complete the corresponding section in the application form.
AstraZeneca is an equal opportunity employer. AstraZeneca will consider all qualified applicants for employment without discrimination on grounds of disability, sex or sexual orientation, pregnancy or maternity leave status, race or national or ethnic origin, age, religion or belief, ... View more